Active Pharmaceutical Ingredients Market
Global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021
Global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By:Zion <strong>Market</strong> Research<br />
Global <strong>Active</strong> pharmaceutical ingredient <strong>Market</strong> Will<br />
Reach around USD 213.84 Billion in 2021<br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zionmarketresearch.com
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
Zion Research has published a new report titled “<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of<br />
Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API<br />
(Synthetic API and Biological API), by Drug Type (Branded Drugs, Generic Drugs and OTC<br />
Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other<br />
Application - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 –<br />
2021”. According to the report, global demand for active pharmaceutical ingredient market<br />
was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021<br />
and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021.<br />
Browse the “Aromatic Solvents <strong>Market</strong>” full report<br />
at https://www.zionmarketresearch.com/report/active-pharmaceutical-ingredientsmarket
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
APIs are frequently referred as "bulk pharmaceuticals”. <strong>Active</strong> pharmaceutical ingredient is<br />
a biologically active portion of any pharmaceutical drug. Occasionally, API needs cofactor in<br />
order to attain specific effects on body. Some active pharmaceutical ingredients are<br />
unidentified and therefore need additional substances, which can work in combination with<br />
the API to generate the required medicinal effect on body. In herbal medicines, the API is<br />
generally a mixture of various substances, which act collectively on the body.<br />
The market for API is expected to have the highest growth rate in the forecast period.<br />
Increasing prevalence of diabetes, neurological disorders and other chronic diseases are the<br />
major driving factor of the global API market. One of the key drivers of the API market is an<br />
increase in the outsourcing of active pharmaceutical ingredients manufactured by<br />
pharmaceutical companies which is done to reduce both manufacturing and infrastructure<br />
costs. Such outsourced manufacturing activities are carried out by low-cost vendors in the<br />
Asia Pacific region.
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
Request sample report at https://www.zionmarketresearch.com/sample/activepharmaceutical-ingredients-market<br />
However, strict regulations are one of the major challenges faced by the global API market.<br />
Such regulations are predominantly well defined in developed regions such as North<br />
America and Europe. Vendors in this market space are supposed to obey the detailed<br />
procedures prior to product commercialization.<br />
The global API market is segmented based on API synthesis, type of manufacturing, and<br />
type of API, application and by region. Depending on synthesis market is classified in to<br />
biotech API, synthetic chemical API, and HPAPI. On the basis of type of drug, the market is<br />
segmented into branded drugs, generic drugs and OTC (Over the Counter) drugs. The<br />
branded drug segment accounted for largest share in 2015. Different therapeutic application<br />
of the API market include cardiology, oncology, anti-inflammatory, gastrointestinal and<br />
others. The oncology segment is anticipated to grow at the highest growth rate in coming<br />
years due to increasing prevalence of cancer worldwide.
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
North America is leading market for API and acquired largest share in 2015. Asia Pacific<br />
region is expected to emerge as fastest growing region due to low operation costs and high<br />
investments in medical research. Furthermore the high cost of trained labor and energy are<br />
the most important factors that enforced European market to move their base to developing<br />
countries such as India and China.<br />
Sun <strong>Pharmaceutical</strong>s Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc.,<br />
Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others are some of<br />
the leading players in API market.<br />
The report segments the global active pharmaceutical ingredient market as<br />
<strong>Active</strong> <strong>Pharmaceutical</strong> Ingredient <strong>Market</strong>: API Synthesis Segment Analysis<br />
<br />
<br />
Biotech API<br />
Synthetic Chemical API
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
<br />
HPAPI<br />
<strong>Active</strong> <strong>Pharmaceutical</strong> Ingredient <strong>Market</strong>: Type of Manufacturing Segment<br />
Analysis<br />
<br />
<br />
Contract Manufacturing<br />
In-House API Manufacturing<br />
<strong>Active</strong> <strong>Pharmaceutical</strong> Ingredient <strong>Market</strong>: Type of API Segment Analysis<br />
<br />
<br />
Synthetic API<br />
Biological API<br />
<strong>Active</strong> <strong>Pharmaceutical</strong> Ingredient <strong>Market</strong>: Drug Type Segment Analysis<br />
<br />
<br />
Branded Drugs<br />
Generic Drugs
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
<br />
OTC Drugs<br />
<strong>Active</strong> <strong>Pharmaceutical</strong> Ingredient <strong>Market</strong>: Therapeutic Application Segment<br />
Analysis<br />
<br />
<br />
<br />
<br />
<br />
Cardiology<br />
Oncology<br />
Anti-Inflammatory<br />
Gastrointestinal<br />
Other<br />
Read "<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong>"Press Release<br />
at https://www.zionmarketresearch.com/news/global-active-pharmaceutical-ingredientmarket
<strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zionmarketresearch.comWeb:www.zionmarketresearch.com
Change language